Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach
ConclusionNo signal of DDIs between DOACs and antineoplastic agents was detected, except for DOAC-neratinib. Most DDIs between DOACs and antineoplastic agents may not be clinically relevant. The DDIs between DOACs and neratinib should be further examined in future research.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Hematology | Oral Cancer | Prednisolone | Restasis | Stroke | Study | Tamoxifen | Thrombosis